| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/08/2006 | EP1325009B1 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 03/08/2006 | EP1294389B1 Therapeutical use of sophora flavescens or sophora subprostrata extracts |
| 03/08/2006 | EP1278770B1 Human wingless-like gene |
| 03/08/2006 | EP1276722B1 Naphthamidine urokinase inhibitors |
| 03/08/2006 | EP1274407B1 Uses of ppar-gamma agonists in neutrophil-induced diseases |
| 03/08/2006 | EP1263422B1 Agent for treating illnesses of the tracheobronchial tract, especially chronic obstructive pulmonary disease (copd) |
| 03/08/2006 | EP1257581B1 Compounds related to or derived from gfr alpha 4 and their use |
| 03/08/2006 | EP1237565B1 Betaglycan as an inhibin receptor and uses thereof |
| 03/08/2006 | EP1218019B1 Oncolytic vesicular stomatitis virus |
| 03/08/2006 | EP1204744B1 Isolated peptide of the horny layer and use thereof |
| 03/08/2006 | EP1178967B1 Quinoline derivatives as inhibitors of mek enzymes |
| 03/08/2006 | EP1123396B1 Minimal promoters and uses thereof |
| 03/08/2006 | EP1102776B1 Water soluble prodrugs of hindered phenols |
| 03/08/2006 | EP1038011B1 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system |
| 03/08/2006 | EP1005460B1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors |
| 03/08/2006 | EP1003774B1 GnRH ANTAGONISTS BEING MODIFIED IN POSITIONS 5 AND 6 |
| 03/08/2006 | EP0800532B1 Improved cyclic crf agonists |
| 03/08/2006 | EP0538402B1 Method of preparing a radioactive rhenium complex solution |
| 03/08/2006 | CN1745299A Method of diagnosis, treatment and useful agents for conditions characterized by modulation in the level of activin beta c |
| 03/08/2006 | CN1745099A 修饰的可溶性t细胞受体 Modified soluble t-cell receptor |
| 03/08/2006 | CN1745090A Steroid compounds with anti-tumor activity |
| 03/08/2006 | CN1745087A Novel tricyclic azepine derivatives, method for production therof and pharmaceutical compositions comprising the same |
| 03/08/2006 | CN1745080A 1,3-dihydroimidazole fused-ring compound |
| 03/08/2006 | CN1745054A Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents |
| 03/08/2006 | CN1744954A Biological control of nanoparticles |
| 03/08/2006 | CN1744930A 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 03/08/2006 | CN1744920A Novel compositions magnetic particles covered with gem-bisphosphonate derivatives |
| 03/08/2006 | CN1744919A Method and composition for treating tumors by selective induction of apoptosis |
| 03/08/2006 | CN1744910A Drugs containing galectin 9 |
| 03/08/2006 | CN1744906A Auxiliary agent to be used in cancer therapy by dielectric heating and cancer therapy method |
| 03/08/2006 | CN1744902A Pharmaceutical combination for the treatment of cancer |
| 03/08/2006 | CN1744901A Use of amphiphilic lipids for the preparation of a pharmaceutical composition for reducing tumor metastasis |
| 03/08/2006 | CN1744892A Breast cancer resistance protein (BCRP) inhibitor |
| 03/08/2006 | CN1744887A Breast cancer-resistant protein inhibitor |
| 03/08/2006 | CN1743337A Taxol derivative and its pharmaceutical composition |
| 03/08/2006 | CN1743330A Aspergillus fumigatus dardarin C analogue, and its synthesizing method and use |
| 03/08/2006 | CN1743327A Indole alkaloid derivative, and its preparing method and use |
| 03/08/2006 | CN1743008A Method for preparing nano liver-target biodegradating medicine carrier material |
| 03/08/2006 | CN1743001A Efficient mixture preparation for intensifying solid tumor cell chemical therapeutic sensitivity |
| 03/08/2006 | CN1742997A Mimetics of interleukin-8 and use of them in the prevention, treatment, diagnosis of a disease |
| 03/08/2006 | CN1742950A Chinese medicine preparation made from corn stigma and preparing method |
| 03/08/2006 | CN1742940A Chinese medicine preparation for tonifying brain and calming nerves and anti-fatigue |
| 03/08/2006 | CN1742866A Anti-cancer Chinese medicine capsule preparation |
| 03/08/2006 | CN1742833A Medicine for bone ischemic necrosis, bone-tracture slow healing and bone disconnecting |
| 03/08/2006 | CN1742832A Chinese medicine preparation for treating cancer and cancer-pain, preparing method and quality control method therefor |
| 03/08/2006 | CN1742783A Natural medicine preparatino for tonifying Qi strengthening body resistance and preparing method |
| 03/08/2006 | CN1742765A Chinese medicine Qikeli polysaccharide and its immunologic preparation |
| 03/08/2006 | CN1742738A Pharmaceutical compositions for cancer therapy |
| 03/08/2006 | CN1742723A Medicine composition containing temozolomide-8-carboxylic ether and use of such compound for preparing anti-tumor medicine |
| 03/08/2006 | CN1742722A Method for resisting blood vessel generation |
| 03/08/2006 | CN1742710A Use of bromoisovanillin in preparing anti-cancer and/or anti-radiation, chemical therapy sensitivity-enhancing medicines |
| 03/08/2006 | CN1244595C Tumor suppressor protein and its application |
| 03/08/2006 | CN1244592C Antisense nucleic acid having inhibiting leukemia cell telomerase activity and its application |
| 03/08/2006 | CN1244591C mRNA antisense nucleic acid with inhibited VEGF expression and its application |
| 03/08/2006 | CN1244589C 腺苷a3受体激动剂 A3 adenosine receptor agonists |
| 03/08/2006 | CN1244583C Tiemomium azoleamine-8-carboxylic acid ester and 8-amide derivatives, its synthesizing method and application in producing anticancer preparation |
| 03/08/2006 | CN1244580C Aminothiazoles and their use as adenosine receptor antagonists |
| 03/08/2006 | CN1244569C C-10 position taxane derivative and its medicine composition |
| 03/08/2006 | CN1244376C Releasable bond and composition containing said bond |
| 03/08/2006 | CN1244375C Human liver regeneration related protein and its application |
| 03/08/2006 | CN1244362C Pill for treating lung disease, and its preparing method |
| 03/08/2006 | CN1244321C Gastric 5-fluorouracil double slow release tablet of float and stay type for treating gastric cancer |
| 03/07/2006 | US7009061 Diterpene compounds |
| 03/07/2006 | US7009049 Syntheses of quinazolinones |
| 03/07/2006 | US7009040 Administering a monoclonal antibody encoded by a clone on deposit which binds specifically to an antigen expressed by a tumor; screening for cancerous cells; biological conjugation with a radioisotope, enzyme toxins and hematogenous cells; antitumor agents; anticarcinogenic agents; cytotoxicity |
| 03/07/2006 | US7009036 Peptide inhibiting platelet derived growth factor (PDGF-BB) and fibroblast growth factor (bFGF) activity |
| 03/07/2006 | US7008956 p53 inhibitors and therapeutic use of the same |
| 03/07/2006 | US7008953 3-((mono- or di-fluoro-benzimidazol-2-yl))-5-(4-methyl-5-(ethylaminomethyl)pyrid-3-yl)indazole; inhibitors of cyclin dependent kinases(CDK) for use treating cancer and other proliferative disorders such as retinopathy, rheumatoid arthritis |
| 03/07/2006 | US7008948 Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors |
| 03/07/2006 | US7008943 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/07/2006 | US7008942 Cytotoxic agents comprising taxanes and their therapeutic use |
| 03/07/2006 | US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient |
| 03/07/2006 | US7008928 Crystals of N2-(N,N-dimethyl-L-valyl)-N-[(1S,2R)-2-methoxy-4-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[(2-phenylethyl)amino]propyl]-1-pyrrolidinyl]-1-[(S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide with potent antitumor activity |
| 03/07/2006 | US7008921 Materials and methods relating to endothelial cell growth inhibitors |
| 03/07/2006 | US7008779 novel gene and protein designated PHELIX; in normal individuals, expressed only in testis, but expressed at high levels in advanced and metastatic prostate cancer, and expressed at lower levels in testicular, bladder, ovarian cancers |
| 03/07/2006 | US7008765 polynucleotides that code for prostate specific antigen proteins or polypeptides; cells containing the recombinant nucleic acid molecules; hybridomas containing the antibodies; kits containing probes or antibodies; prevention of prostate cancer |
| 03/07/2006 | US7008649 administering compositions of eugenol and forskolin; for treating and/or preventing soft tissue cancer in mammals |
| 03/07/2006 | US7008643 Delivery system for biological material |
| 03/07/2006 | US7008640 Mixture of drug, aminoacrylate polymer and acid |
| 03/07/2006 | US7008633 Injection of a biocompatible polymer, polysaccharide or polyamino acid, a cross-linker, and therapeutic agent into tumor; hydrogel formed in the tumor retains the therapeutic agent |
| 03/02/2006 | WO2006023865A1 Oxazolo-naphthyl acids as plaminogen activator inhibtor type-1 (pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases |
| 03/02/2006 | WO2006023714A2 Dithiocarbamate derivatives and their use for treating cancer |
| 03/02/2006 | WO2006023639A1 Methods and compositions for oral delivery of fts |
| 03/02/2006 | WO2006023395A2 4-(2,4-dichloro-5-methoxyphenyl)amino-6-methoxy-7-{[5-(substituted-amino)methyl]-3-furyl}-3-quinolinecarbonitriles as kinase inhibitors |
| 03/02/2006 | WO2006023242A1 Benzoxazepine derivatives as selective estrogen receptor modulators |
| 03/02/2006 | WO2006022442A1 Novel heterocyclic amide derivatives having dihydroorotate dehydrogenase inhibiting activity |
| 03/02/2006 | WO2006022374A1 2-phenylpyridine derivative |
| 03/02/2006 | WO2006022356A1 Process for producing microorganism fat containing diacylglycerol in any amount and the fat |
| 03/02/2006 | WO2006022344A1 Utilization of anti-mortalin 2 antibody and functional nucleic acid in treating cancer |
| 03/02/2006 | WO2006022340A1 Composite fine particles and process for producing the same |
| 03/02/2006 | WO2006022338A1 Dry powder of pseudo leaf tissue of plant belonging to the genus asparagus |
| 03/02/2006 | WO2006022234A1 NFATc1 EXPRESSION INHIBITOR, OSTEOCLAST DIFFERENTIATION OR ACTIVATION INHIBITOR, AND PHARMACEUTICAL COMPOSITION |
| 03/02/2006 | WO2006021888A2 Dihydrofolate reductase inhibition by epigallocatechin gallate compounds |
| 03/02/2006 | WO2006021883A2 Ventilation system and device for shoes |
| 03/02/2006 | WO2006021881A2 Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors |
| 03/02/2006 | WO2006021660A1 Use of at least one conjugated triene-containing fatty acid for preparing a medicine for treating inflammation |
| 03/02/2006 | WO2006021653A2 Azasugar derivatives, heparanase inhibitors, method for preparing same, compositions containing same, use thereof |
| 03/02/2006 | WO2006021548A1 Dihydropteridinones, method for the production thereof, and use thereof as a medicament |
| 03/02/2006 | WO2006021547A1 Pteridinones used as plk (polo like kinase) inhibitors |
| 03/02/2006 | WO2006021544A1 2,4-di(aminophenyl) pyrimidines as plk inhibitors |